Accessibility Menu
Lonza Group Ag logo

Lonza Group Ag(OTC) LZAGY

Current Price$67.09
Market Cap$46.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+771%
5 Year-9%
1 Year-5%
1 Month+3%
Lonza Group Ag last closing stock price
MetricPriceDate
Last closeUSD 67.092026-07-24
Lonza Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.4%USD 70.182026-07-17
1 month+3.37%USD 64.902026-06-24
3 month+9.89%USD 61.052026-04-24
Year to date+0.78%USD 66.572025-12-31
1 year-4.85%USD 70.512025-07-24
3 year+20%USD 55.912023-07-25
5 year-9.33%USD 73.992021-07-23
Since inception+771.15%USD 7.702008-10-16

Lonza Group Ag Financials at a Glance

Market Cap

$46.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 13.49B

Net Income (TTM)

CHF 1.86B

EPS (TTM)

-$0.18

P/E Ratio

-383.15

Dividend

$0.32

Beta (Volatility)

0.80 (Low)

Price

$67.09

Volume

135,529

Open

$67.00

Previous Close

$67.09

Daily Range

$66.54 - $67.17

52-Week Range

$58.53 - $73.85

Estimated Earnings Date

Jul 22, 2026

LZAGY News

GettyImages-1276584541

Should You Have Lonza Stock on Your Watchlist?

Keith SpeightsNov 13, 2021
colorful-pills-on-cash-money-getty

Lonza Swipes a Top Roche Executive to Be Its Next CEO

Cory RenauerJun 5, 2020
scientist research laboratory

Moderna and Novavax are Making Strides in Advancing Novel Coronavirus Vaccine Research

Michael Dean McGrady JrMay 16, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lonza Group Ag

Lonza Group AG is a leading global provider of pharmaceutical, healthcare, and life science products. The company operates through various segments, including Biologics, Small Molecules, Cell and Gene, and Capsule and Health Ingredients, catering to diverse client needs across the product lifecycle.

Products and Services
  • Biologics: Contract development and manufacturing for biopharmaceuticals
  • Small Molecules: Integrated drug substance and product solutions
  • Cell and Gene: Development and commercialization of emerging therapies
Growth Outlook
  • Projected revenue growth driven by increasing demand in biopharmaceuticals
  • Expansion in Cell and Gene segment expected to enhance market position
  • Strategic investments in R&D to foster innovation and product development
Financial Highlights
  • Recent quarterly revenue of 2.96 billion CHF, reflecting strong market demand
  • Trailing twelve months (TTM) gross profit margin at 34.63%, indicating operational efficiency
  • Net income of 523 million CHF in the latest quarter, showcasing profitability
Lonza Group AG has established itself as a key player in the biotechnology sector, with a robust portfolio of products and services that cater to the evolving needs of the pharmaceutical industry. The company's focus on innovation and strategic growth initiatives positions it well for future expansion. Recent financial performance highlights a strong revenue base and profitability, underscoring the company's operational effectiveness. With a commitment to advancing healthcare solutions, Lonza Group AG remains a compelling option for investors interested in the biotechnology space.
AI Generated • Jul 20, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

16,866

CEO

Wolfgang Wienand, PhD

Website

www.lonza.com

Headquarters

Basel, BS 4002, CH

LZAGY Financials

Key Financial Metrics (TTM)

Gross Margin

35.79%

Operating Margin

23.02%

Net Income Margin

-1.74%

Return on Equity

-1.28%

Return on Capital

9.65%

Return on Assets

-0.60%

Earnings Yield

-0.26%

Dividend Yield

0.47%

Payout Ratio

-3.39%

Stock Overview

Market Cap

$46.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

698.44M

Volume

135.53K

Avg. Volume

66.20K

Financials (TTM)

Gross Profit

CHF 4.68B

Operating Income

CHF 2.57B

EBITDA

CHF 3.79B

Operating Cash Flow

CHF 2.61B

Capital Expenditure

-CHF 2.75B

Free Cash Flow

-CHF 147.56M

Cash & ST Invst.

CHF 487.00M

Total Debt

CHF 4.17B

Lonza Group Ag Performance Analysis

Lonza Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 6,515,786,09010.1%
20232023-12-31CHF 7,474,530,58714.7%
20242024-12-31CHF 6,222,552,302-16.7%
20252025-12-31CHF 7,864,067,67926.4%
Lonza Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3115.0%
Q22025-06-301.7%
Q42025-12-31-17.4%
Q22026-06-3016.6%
Lonza Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 1.71-60.4%
20232023-12-31CHF 0.99-42.3%
20242024-12-31CHF 1.012.6%
20252025-12-31CHF -0.47N/A
Lonza Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-6.9%
Q22025-06-3041.5%
Q42025-12-31-263.3%
Q22026-06-30186.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 3.45B

+12.7%

Gross Profit

CHF 1.32B

+18.5%

Gross Margin

38.38%

N/A

Market Cap

$46.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.78M

N/A

Employees

16,866

N/A

Net Income

CHF 603.71M

+83.5%

EBITDA

CHF 1.17B

+41.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 487.00M

-75.9%

Total Debt

CHF 4.17B

+9.8%

Accounts Receivable

CHF 1.92B

+23.8%

Inventory

CHF 1.88B

+9.7%

Long Term Debt

CHF 3.39B

-6.8%

Short Term Debt

CHF 774.00M

+399.4%

Return on Assets

-0.60%

N/A

Return on Invested Capital

10.34%

N/A

Free Cash Flow

CHF 82.74M

+170.7%

Operating Cash Flow

CHF 674.20M

+33.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLNCFHaleon plc
$4.86-2.12%
HOCPFHOYA Corporation
$154.17+0.00%
UCBJYUCB S.A.
$139.01+0.71%
UCBJFUCB S.A.
$290.59+4.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%
FFord Motor Company
$14.37+0.02%

Questions About LZAGY

What is the current price of Lonza Group Ag?

Lonza Group Ag is trading at $67.09 per share.

What is the 52-week range for Lonza Group Ag?

Over the past 52 weeks, Lonza Group Ag has traded between $58.53 and $73.85.

How much debt does Lonza Group Ag have?

As of the most recent reporting period, Lonza Group Ag reported total debt of CHF 5.73B.

How much cash does Lonza Group Ag have on hand?

Lonza Group Ag reported CHF 907.54M in cash and cash equivalents in its most recent financial results.

What is Lonza Group Ag’s dividend yield?

Lonza Group Ag currently has a dividend yield of 0.47%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services